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Abstract 
 
 
 
Objective:  The objective of this systematic review is to determine whether Kangaroo Care is 
effective in reducing procedural pain in neonates. 
 
Study Design:  Review of three English language single-blind randomized, controlled trials from 
2008.  
 
Data Sources:  Randomized, single-blind control trials comparing Kangaroo Care to standard 
Incubator Care as analgesia for neonates during routine medical procedures. All studies were 
located using the OVID, Medline, and Cochrane databases. 
 
Outcomes Measured:  Neonate pain to minimally invasive routine medical procedures including 
vitamin K injection and heel stick. Neonate pain includes parameters of both audible and 
inaudible crying. All three of the studies utilized standardized scoring systems to rate facial cues 
and behavioral indicators of neonate pain and distress. These scoring systems include the 
Andersen Behavioral State Scoring System, the Neonatal Infant Pain Scale, and the Premature 
Infant Pain Profile.  
  
Results:  Mean crying times and facial indicators of distress were significantly decreased in 
neonates receiving Kangaroo Care versus the standard Incubator Care. No adverse events or 
effects were reported from implementation of the KC intervention. 
 
Conclusion:  All of the studies reviewed demonstrate that Kangaroo Care is effective in reducing 
neonate pain and distress during routine minimally invasive medical procedures. Further research 
is needed to determine the optimal amount of Kangaroo Care time needed for individual 
procedures.  Likewise, further research should examine paternal and/or surrogate caregivers as 
the bonding partner. The easy availability, cost effectiveness, and natural bonding of Kangaroo 
Care make it a promising addition to the nonpharmacologic interventions available for 
alleviating neonate pain and distress.  
 
Key Words: Kangaroo Care, Skin to Skin Contact, pain, infant, neonate 
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Introduction 
 Neonates undergo multiple stressors from the time of birth to discharge from the hospital 
setting.  Most of these processes-APGAR scoring, heel sticks, vitamin K injections and the like 
are required to ensure the health of a newborn or to determine cause of current or future illness. 
The pain and distress experienced by the neonate and by proxy the caregivers from such 
procedures make it desirable to have an arsenal of both pharmacologic and nonpharmacologic 
interventions available to minimize this distress; especially for those procedures that are invasive 
in nature such as venipuncture and injections.    
 Currently, many of the aforementioned procedures are performed while the neonate is 
within the confines of an incubator. Incubator care (IC) is therefore the current standard for early 
observation of the neonate as incubators are well equipped with warming mechanisms, and 
monitoring devices. Additionally, incubators can be isolated if need be for the fragile preterm or 
seriously ill neonate. In the studies reviewed, standard IC involves placing the neonate prone in 
the incubator surrounded or “nested” in blankets at incline of 30-45°.1 When oral glucose (OG) is 
implemented for analgesia, the neonate is administered oral sugar solution prior to the painful 
stimulus in addition to being placed per standard IC measures. Caregiver-neonate interaction is 
limited with the use of IC, due to the inherent isolation of the incubator module. This interaction 
is further minimized during procedures as incubators are often limited to designated areas of the 
healthcare facility, and workable space comes at a premium in most nursery settings.  
With the conception of Kangaroo Care (“Skin to Skin Contact”) the neonate and 
caregiver are in direct physical contact with each other, thus allowing for the comfort, 
familiarity, and scent of the caregiver to soothe the neonate whilst the procedure is being 
performed. Kangaroo Care (KC) is a nonpharmacologic intervention being used in some medical 
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settings to allay neonate pain and distress during minor invasive procedures. The KC procedure 
involves placing an undressed, diapered infant upon the mother’s bare chest “skin to skin” as she 
sits comfortably at a 45-60° angle.
1,2,3
  The neonate’s back is covered with a blanket, and the 
mother holds the child in position with a firm grip. For the studies, the caregiver is to remain in 
this position with the neonate undisturbed for the duration of the intervention period. Other 
parent-child interaction is discouraged and outside stimulus is minimized throughout the study 
period.  
Pain inflicted from procedures such as heel sticks-for blood glucose checks and the 
newborn screening, and vitamin K injections are some of the first invasive procedures 
experienced by term and preterm neonates in the hospital setting.  Both healthy and ill neonates 
undergo a number of these tests in the first few hours and days of life. Preterm and ill neonates 
may experience an exponentially greater number of such procedures. Evidence shows that 
repeated painful stimuli can provoke physiologic and hormonal changes thus affecting the 
neurobiology and CNS development of the neonate.
1
 Moreover, research demonstrates that 
preterm infants may lack the pain inhibition abilities of their full term cohorts, leaving them 
more sensitive to pain and at greater risk for developing maladaptive pain responses.
1,3
   
If proven effective, Kangaroo Care offers a promising new intervention to decrease 
neonate procedural pain.  KC affords many advantages over other interventions. It is cost 
effective, requiring little to no additional overhead. KC can be utilized in any setting that serves 
neonates; such that hospitals, clinics, ERs and Urgent Care facilities may benefit from its use. As 
a nonpharmacologic intervention, midlevel providers such as Physician Assistants and Nurse 
Practitioners as well as other designated medical staff may initiate KC without requiring a 
Physician’s signature. Availability and ability of the caregiver and neonate are essentially
the only prerequisites needed for implementation of the KC intervention.  
Objective 
 The objective of this systematic review is to determine whether or not, “Is Kangaroo Care 
effective in reducing procedural pain in neonates?”  Previous research has concluded that KC is 
effective for promoting preterm neonate development, including thermoregulation and 
respiratory maturation.  Other randomized, controlled trials have shown promising results using 
KC in other avenues of neonate care. However, limited studies are available on the effectiveness 
of KC in alleviating neonate pain during routine invasive medical procedures.  
Methods 
 For this review, the author performed a detailed search of the Cochrane, Ovid and 
Medline Databases for Randomized Controlled-Trials and Systematic Reviews. Search criteria 
included English language, peer reviewed journal articles published from 2005 to present. Key 
search terms used: “Kangaroo Care,” “Skin to skin contact,” “pain,” “infant,” and “neonate.” Of 
those RCTs selected, the subject population included both term and preterm neonates undergoing 
routine minimally invasive medical procedures. Articles chosen were based on relevance and 
validity to the objective in question.  
 The studies selected for this review were all randomized, controlled trials with measures 
based on patient oriented outcomes (POEMs). Two of the selected studies compared KC with 
IC.
2,3
  A third study compared these and oral glucose (OG) as analgesia as well.
1
 Two of the 
studies enrolled preterm neonates with 28-36 weeks and 30-32 weeks gestational age 
respectively.
1,3
  In contrast, the Kashaninia group studied full term neonates > 37 weeks 
gestational age. The painful stimulus experienced by study subjects was either routine heel stick 
or intramuscular vitamin K injection.
1,3,2
  Studies excluded from this review were those that 
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involved KC in subjects older than neonate age, or those undergoing medical procedures where 
piercing of the skin was not involved. Demographics of the studies included in this review can be 
found in Table 1. All three studies utilized standardized tools for measuring neonate 
pain/distress. The statistics used in each study are somewhat variable, with results performed by 
ANOVA and Kruskal-Wallis testing; all studies include p-values.  
Table 1: Demographics of reviewed studies 
 
Study 
 
Type # of 
Pts 
Age Inclusion 
Criteria 
Exclusion 
Criteria 
W/D Interventions 
Freire,  
Brazil, 2008 
RCT, 
Single-
blind 
105 Preterm  
28-36 wks  
GA 
Healthy 
neonates, 
 Healthy 
mothers 
Congenital anomalies, 
Maternal drug use, 
Ventilation  
support,  
Intraventricular 
hemorrhage 
Chest drain, 
Tracheotomy, Oxygen 
therapy, 
Hemodynamic 
instability, 
Analgesia/sedative 
care within 48 hours  
10 Incubator care 
without 
analgesia, 
Glucose as 
analgesia, 
Kangaroo 
care-10 mins 
prior and 
during 
procedure 
Kostandy,  
USA,  
2008 
RCT,  
Prospective 
cross-over 
10 Preterm 
30-32 wks 
GA;  
post-natal 
age of 
2-9 days 
Healthy 
neonates, 
Healthy 
English-
speaking  
mothers,  
NPO or 
bolus fed 
over 20 
mins 
 
Congenital anomalies,  
Maternal drug use, 
Intraventricular 
hemorrhage,  
Surgical history,   
Heel inflammation, 
Sedative or analgesia 
treatment within 24 
hours 
0 Incubator care-
30 mins 
undisturbed, 
then 
procedure, 
then 20 min 
recovery, 
Kangaroo 
care-kept in 
position 30 
mins prior, 
during and 20 
mins after 
procedure 
Kashaninia,  
Iran, 2008 
RCT, 
Gender-
matched  
100 Full term  
37 wks 
GA, 
Approx 2 
hr post-
natal age 
2500-4000g 
at birth, 
APGAR >7 
at 1 min old, 
HR 100-160 
bpm,  
pO2 > 95%, 
Unfed 
 
Congenital anomalies,  
Maternal drug use 
Caesarean birth, 
Administration of any 
injection of vaccine,  
Birth trauma 
0 Incubator quiet 
time,  
Kangaroo care, 
both for 10 
mins prior to 
procedure 
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Outcomes Measured 
Outcomes measured were based on importance to the patient, and in this case the 
caregiver as well. The outcomes measured include expressive cues of neonate pain/distress that 
could be easily read by the caregiver and/or hospital staff. All studies used for the review utilized 
standardized tools for recognizing and scoring infant pain and distress. One study employed the 
Neonatal Infant Pain Score (NIPS) to account for infant facial expression, crying indicators, and 
to compile a cumulative score.
2
 The Andersen Behavioral State Scoring System (ABSSS), which 
calculates both audible and inaudible crying times from relevant facial cues, neonate level of 
arousal and activity was used by another.
3
 The third research group utilized the Premature Infant 
Pain Profile (PIPP) scoring model to measure eye squeeze, brow bulge, and nasolabial furrowing 
as signs of neonatal pain.
1 
 All studies used videotaping and blinded raters for scoring. 
Results 
Each of the studies presented in this review are randomized, controlled trials with the 
intention to treat pain experienced by neonates during routine medical procedures. Two of three 
studies compared Kangaroo Care with standard Incubator Care, while the third also compared 
oral glucose as an intervention.
2,3,1
  The Kashaninia group utilized intramuscular vitamin K 
injection as the painful stimulus, while both of the other studies used heel stick procedures.
1,3
 
The Freire et al study began with the most participants at 105, but lost 10 due to blinding errors. 
Thus the Kashaninia et al study completed with the largest study population at 100. As a pilot 
study, the Kostandy et al population was limited to 10 subjects. This group also experienced 
blinding errors as one neonate subject was noncompliant to study conditions.   
All studies reviewed here utilize standardized tools for measuring neonate distress. Such 
measures include the NIPS, ABSSS, and PIPP scoring systems. Although each tool measures 
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slightly different signs of distress, overlap did occur and such indicators included audible crying 
times and facial cues like brow bulge, grimacing expression, and eye squeeze.
1,2,3
  All data 
presented amongst the studies is continuous. Only the scales used by the Kashaninia group were 
convertible to dichotomous data for purposes of this review. 
Kashaninia et al utilized the NIPS scoring system for infant pain and distress. Cumulative 
NIPS scoring was tiered and assessed values:  
No to Mild pain (0-2), Moderate pain (3-4), Severe pain (> 4)  
For purposes of this review, scores of no to mild pain (0-2) constituted successful interventions 
whereas scores of moderate to severe pain (>3) were considered failures. As such, 62% of the 
KC intervention group experienced no to mild pain, while only 2% of the IC control group 
scored similarly. Of the 38% of the KC group scoring at a 3 or above only 6% demonstrated 
indicators of severe pain. Of those in the 98% of IC group failures, 60% scored a 4 or above 
indicating severe pain. P-values for all of the statistics as presented in this research indicated 
statistical significance (p < 0.001). Table 2 highlights the clinical significance and treatment 
benefit of using KC as compared to IC as presented by Kashaninia et al.   
Table 2: Analysis of NIPS Score Outcomes Immediately after Intramuscular Injection  
 
Measured Response  RBI ABI NNT p-value 
Cry Response   1.136 0.50 +2 p < 0.001 
Facial Expression 15.667 0.47 +3 p < 0.001 
Cumulative NIPS score 30.000 0.60 +2* p < 0.001 
RBI=Relative benefit increase, ABI=Absolute benefit increase, NNT=Number needed to treat. 
*Based on the cumulative NIPS score analysis the practitioner would need to treat 2 neonates 
with KC to reduce pain in 1 neonate during IM injection of vitamin K. 
 
 The Kostandy group implemented a randomized cross-over study design utilizing either 
KC or IC as the day 1 intervention and switching to the contrary intervention on day 2. The 
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ABSS system was used for measuring neonate distress across four phases for each condition on 
each day. The phases were continuous from 1) baseline, 2) heel warming, 3) heel stick, and 4) 
recovery. The mean total of audible and inaudible crying time was recorded for each subject. 
Inaudible crying times were minimal throughout each phase, from 0-1.34 seconds across both 
groups on both days. A distinct pattern of crying time emerged in that crying was minimal during 
baseline warming, increased during the heel stick procedure, and then declined during the 
recovery phase on both days of the study regardless of the intervention used. ANOVA testing 
was performed and the results are listed in Table 3. 
Table  3: Efficacy of Kangaroo Care in Decreasing Mean Crying Time 
 Kangaroo  Care Incubator Care   
 Mean Crying 
Time (sec) 
SD Mean Crying 
Time (sec) 
SD ANOVA 
F score 
p-value 
Day 1  
Recovery phase 
  5.83   7.63 25.50 41.93 NR NR 
Day 2 
Heel stick phase 
55.00 55.53 96.17 92.42 F (1,8) = 7.76 p = 0.001 
Days 1 &2 
(combined 
across phases) 
NR NR NR NR F (1,8) = 10.25 p < 0.001 
 NR=Not Recorded;  SD=Standard Deviation 
Kostandy et al report that differences were minimal between groups during the baseline 
and warming phases. In contrast, considerable differences were discovered during the heel stick 
and recovery phases, with the day 2 heel stick phase showing the most significant difference in 
crying time between groups [F (1,8) = 7.76; p = 0.001].  The KC intervention neonates 
experienced significantly less crying time during heel stick than the IC group. The ANOVA 
results show a significant difference in combined crying time between phases on both days  
[F (1,8) = 10.25; p < 0.001]. 
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Freire et al compared three interventions for reduction of heel stick pain in neonates: IC, 
KC, and OG. Those subjects randomized to the OG group were administered 1 mL of oral 
glucose solution by syringe 2 seconds prior to heel stick, and were otherwise placed prone at a 
30-45° incline similar to those in the IC group. Behavioral indicators were measured for 30 
seconds following the painful stimulus using the PIPP scoring model. These parameters included 
brow bulge, eye squeeze, and nasolabial furrowing.  
Kruskal-Wallis statistical tests were performed on each parameter. A significant 
difference was seen across parameters between groups, with a smaller difference observed 
between KC and OG groups as compared to the IC group. Moreover, scores were significantly 
lower in the KC group than either of the other two groups. An abbreviated listing of the results is 
provided in Table 4. ANOVA tests were also performed in this study for physiologic measures of 
heart rate and oxygen saturation (p-value < 0.05). However, as these outcomes are difficult to 
assess by non-medical personnel (i.e. an untrained caregiver), these statistics were excluded from 
this review.  
Table 4: Abbreviated Summary of Behavioral Indicators before and after painful stimulus  
Facial Cue Incubator  
Control (n=33) 
Kangaroo 
Care (n=31) 
Oral Glucose 
(n=31) 
p-value 
 
Brow Bulge 2.33 + 0.64 0.96 + 0.87 1.48 + 0.92 0.0001 
Eye Squeeze 1.75 + 0.79 0.54 + 0.88 1.06 + 0.81 0.0001 
Nasolabial Furrowing 1.75 + 0.75 0.48 + 0.85 1.00 + 0.81 0.0001 
All results listed as mean + SD  
Discussion 
 Across all three studies reviewed, Kangaroo Care does appear to be more effective than 
standard incubator care in treating neonate pain due to minimally invasive procedures. Audible 
crying times were less in the KC groups versus the IC groups across all studies. Results in the 
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cross-over study were most profound during heel stick and recovery phases and more so on day 2 
of the interventions.
2
 It should also be noted that no adverse events were reported with any of the 
interventions used. 
 All studies reviewed here encountered limitations. As a pilot study, Kostandy et al had a 
sample population much too small to establish any correlations. Also, within this study it states 
that “80% of subjects had previous KC experience.”3 Having a sample population with previous 
exposure to the intervention in question may skew the results of the current research and must be 
accounted for. The Freire study was also troublesome, as information on enrollment methods and 
inclusion criteria was somewhat limited.  
All studies had issues with blinding. This caused the majority of withdrawals accounted 
for in this review. Videotaping was used to assist in rating the NIPS, ABSSS, and PIPP 
measures. Due to the nature of the KC intervention, only single-blindedness could be achieved. 
This too was limited as some neonates did move during taping and response rating issues arose. 
Another limitation in regard to rating, involved those actually scoring the responses. Only one 
study utilized a multiple rater system and determined inter-rater reliability to score each subject 
for data purposes.
2
  Both of the other studies used a single rater, and did not account for any bias 
that may have occurred from this practice.     
 The optimal amount of time for KC to be effective in reducing neonate pain remains to be 
determined. Of the three studies reviewed, the KC intervention was initiated from 10 to 30 
minutes prior to the painful stimulus, and continued from 0 to 20 minutes post-procedure.
1,3,2
 
Yet, concomitant outcome responses were measured and scored for periods as short as 30 
seconds post-procedure.
1 
 Such a disparity between time frames provokes inquiry as to whether 
the post-procedure follow up and scoring should be based on a longer review period.    
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 Strengths of the studies were multiple. The Kashaninia group effectively performed a 
randomized gender-matched trial with a solid population size. The use of standardized measures 
for scoring neonate pain and distress were well conceived. Kostandy et al benefited from using 
the ABSS system as it measures both audible and inaudible cry times.    
 Kangaroo Care shows promise as a nonpharmacologic intervention for use in treating 
neonate pain and distress during routine minimally invasive medical procedures. It requires low 
to no overhead costs to implement. It can be initiated by healthcare providers at multiple levels 
without a physician’s authorization. The requirements to carry out the intervention are minimal, 
and depend on the ability and availability of the neonate and caregiver involved.   
Conclusion 
The studies reviewed demonstrate that Kangaroo Care is effective in reducing procedural 
pain in neonates; and that it is more effective than standard incubator care in doing so. Further 
research should focus on specific painful procedures and optimal periods of KC as intervention. 
KC research should be expanded to include similar medical procedures in those infants beyond 
neonate age, say up to 12 months old. Likewise, research should also be conducted with KC and 
the paternal caregiver and/or a designated surrogate. Modern family situations are complex, 
maternal caregivers may fall ill or die from complications of labor and delivery; yet Kangaroo 
Care offers an intervention with potentially few limitations. As long as a willing bonding partner 
is available to the neonate, and that partner is comfortable and able to perform the procedure, it is 
expected to be successful. The neonate will sense stress from the bonding partner whether 
mother, father or surrogate if that partner is anxious about the intervention. Perhaps, further 
researchers should also survey the caregiver to assess his/her level of anxiety about participating 
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in the Kangaroo Care intervention and about observing the neonate in pain. It is inherent for 
many caregivers to be distressed from anticipating or observing one’s child in pain. 
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